THE DEADLINE TO PRESENT AT OIS XIII IS APPROACHING
Looking to enhance your company's visibility and showcase your mission, novel therapies, and developmental progress? Applications are open to present at our upcoming event, OIS XIII. Apply to present and gain access to a global platform featuring a high-quality audience of industry leaders, venture capitalists, KOLs, and analysts.
SPONSOR AN OIS EVENT
Partner with us through sponsorship, and together we can tackle crucial challenges affecting the development and commercialization of innovative ophthalmic products. By doing so, you'll enhance your brand recognition as a pioneer, showcase your company's technology and business goals, and gain valuable access and collaboration opportunities with OIS faculty and leadership. Join us in addressing key issues that are impacting product development and commercialization of novel ophthalmic products and in turn develop brand awareness as an innovator, feature your company’s technology and/or business objectives, and obtain access and collaboration with OIS faculty and leadership.
RECENT OPHTHALMIC NEWS
This week's ophthalmic news updates include Apellis Pharmaceuticals addressesing the retinal vasculitis cases linked to SYFOVRE® (pegcetacoplan injection) HCP, a study revealing that biomarkers detected through retinal imaging could signal Parkinson's disease up to seven years before clinical symptoms appear and results from 17 clinical trials show why you might want to save your money when it comes to blue-light lenses.
